National
Drug Registry

Report adverse effectHelp
SIEN

NATIONAL DRUG REGISTRY

Report adverse effectHelp
SIEN
  2. Humalog Mix50 100 i.e./ml Pen suspenzija za injiciranje

Humalog Mix50 100 i.e./ml Pen suspenzija za injiciranje

Insulin lispro

GeneralCompositionPackagingSmPCDocuments

Composition and organoleptic properties

NameRoleStrengthStrength expression
insulin lispro—100 [IU]/1 ml—
Organoleptic description—

Drug status

Announced permanent cessation of marketing of the medicinal product.
Last drug update date:9. 7. 2026
TEST APPLICATION